Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Dosing problems

In the first case where up is very small, it is like a dosing problem. From (10-28), x = 0.0099. Since x 1, m] is very close to 1 by (E10-5). Thus interaction is not significant if we pair x with nij, and F with m2. Physically, we essentially manipulate the total flow with the large solvent flow m2 and tune the solute concentration by manipulating m,. [Pg.207]

As we mentioned, in one-dimensional problems it might be advantageous to solve the equation f (x) =0 instead of minimizing f. The roots of f (x) = 0 are, however, not necessarily minimum points, and hence we can run into trouble without a good a priori knowledge of the form of the function. In addition, we need an expression for the derivative f (x) which is frequently not available, e.g., in the optimal dosing problem of this section. [Pg.98]

For highly water-soluble compounds, dissolution and absorption usually are complete within a few hours or less (given that permeability is adequate). For compounds with short half-lives, repeated dosing may be required to maintain in vivo drug concentrations within therapeutical levels. In these cases, extended release dosage forms are suitable to overcome the frequent dosing problem, leading to better patient compliance. [Pg.156]

Briggs FE, Mark LK, Faris RJ, et al. 2002. Innovative solutions to a missing dose problem. American Society of Health System Pharmacy Summer Meeting, Baltimore, MD. [Pg.111]

Formulations will increasingly become more complex as the content of the antibiotic is raised within the liposomes [91], and stability is a general concern Dispersions may exhibit aqueous stability of only a matter of days. This issue has partially been addressed through the use of reconstituted lyophilized preps, and a formulation of anamycin has demonstrated over 3 months stability in the solid state [56]. Beauloac et al. [58] have taken this one step further by aerosolizing a dry powder of lyophilized liposome-tobramycin to administer to mice infected with Pseudomonas aeruginosa. [58]. However, the use of powdered preparations does not address the dosing problem. [Pg.571]

Dosing problems that may not seem obvious to most professionals are the problems that occur with liquid medications. Most clients will simply use a kitchen spoon, but all spoons are not the same size. Conunon tableware teaspoons come in various sizes, from 2.S milliliters (ml) to... [Pg.57]

A simple explanation or demonstration of how to measure liquid medicines would prevent dosing problems. When using instruments such as oral syringes, remind the client and family members to remove the cap in order to prevent injury from swallowing it (Kurtzweil, 1994). [Pg.58]

Diaphragm, piston, and peristaltic pumps all deliver liquids in pulses. This uneven delivery can cause dosing problems when mixing is not sufflcient to ensure a rapid distribution of the chemical into the process water stream. Devices and systems are available to help smooth the delivery from these types of pumps. These devices are sometimes called pulsation dampeners (Figure 7-6). There are several designs. [Pg.79]

Using the. results (roiri the previous two problems, evaluate the integrals in the answer to Problem 5 and find t as a dosed algebraic expression for the Gaussian trial runetion. [Pg.199]

Common side effects of theophylline therapy include headache, dyspepsia, and nausea. More serious side effects such as lethal seizures or cardiac arrythmias can occur if blood levels are too high. Many derivatives of theophylline have been prepared in an effort to discover an analogue without these limitations (60,61). However, the most universal solution has resulted from the development of reHable sustained release formulations. This technology limits the peaks and valleys in semm blood levels that occur with frequent dosing of immediate release formulations. ControUed release addresses the problems inherent in a dmg which is rapidly metabolized but which is toxic at levels ( >20 7g/mL) that are only slightly higher than the therapeutically efficacious ones (10—20 p.g/mL). Furthermore, such once-a-day formulations taken just before bedtime have proven especially beneficial in the control of nocturnal asthma (27,50,62). [Pg.440]

Treatment of Manic—Depressive Illness. Siace the 1960s, lithium carbonate [10377-37-4] and other lithium salts have represented the standard treatment of mild-to-moderate manic-depressive disorders (175). It is effective ia about 60—80% of all acute manic episodes within one to three weeks of adrninistration. Lithium ions can reduce the frequency of manic or depressive episodes ia bipolar patients providing a mood-stabilising effect. Patients ate maintained on low, stabilising doses of lithium salts indefinitely as a prophylaxis. However, the therapeutic iadex is low, thus requiring monitoring of semm concentration. Adverse effects iaclude tremor, diarrhea, problems with eyes (adaptation to darkness), hypothyroidism, and cardiac problems (bradycardia—tachycardia syndrome). [Pg.233]

In 1969, a chronic toxicity study on a cyclamate saccharin (10 1) blend indicated bladder cancer problems in rats. Cyclamate was soon banned by the FDA, but saccharin remained an approved sweetener. In 1977, the FDA proposed a ban on saccharin because of the discovery of bladder tumors in some male rats fed with high doses of saccharin. Because no other nonnutritive sweetener was available at that time, the proposed ban faced strong opposition. [Pg.276]

Fig. 10. Two materials, A and B, have statistically similar LD q values but, because of differences ia the slopes of the dose—mortaUty regression lines, there are significant differences ia mortaUty at the LD q and LD jq levels. Material A is likely to present problems with acute overexposure to large numbers of iadividuals ia an exposed population when lethal levels are reached. With Material B, because of the shallow slope, problems may be encountered at low... Fig. 10. Two materials, A and B, have statistically similar LD q values but, because of differences ia the slopes of the dose—mortaUty regression lines, there are significant differences ia mortaUty at the LD q and LD jq levels. Material A is likely to present problems with acute overexposure to large numbers of iadividuals ia an exposed population when lethal levels are reached. With Material B, because of the shallow slope, problems may be encountered at low...
Generally, nephrotoxicity is not a problem. Some cephalosporins, especially those with the 3-methylthiotetrazole side chain, such as moxalactam (48), show a tendency to promote bleeding. This appears to be due to a reduction in the synthesis of prothrombin and can be a problem especially in elderly patients, patients with renal insufficiency, or patients suffering from malnutrition (219). The same side chain seems to promote a disulfiramlike reaction in patients consuming alcohol following a cephalosporin dose (80,219). [Pg.39]


See other pages where Dosing problems is mentioned: [Pg.14]    [Pg.258]    [Pg.211]    [Pg.336]    [Pg.172]    [Pg.24]    [Pg.202]    [Pg.121]    [Pg.503]    [Pg.72]    [Pg.531]    [Pg.402]    [Pg.73]    [Pg.14]    [Pg.258]    [Pg.211]    [Pg.336]    [Pg.172]    [Pg.24]    [Pg.202]    [Pg.121]    [Pg.503]    [Pg.72]    [Pg.531]    [Pg.402]    [Pg.73]    [Pg.803]    [Pg.1645]    [Pg.1800]    [Pg.391]    [Pg.48]    [Pg.176]    [Pg.812]    [Pg.532]    [Pg.114]    [Pg.222]    [Pg.531]    [Pg.40]    [Pg.75]    [Pg.107]    [Pg.38]    [Pg.238]    [Pg.409]    [Pg.469]    [Pg.439]    [Pg.489]    [Pg.234]    [Pg.236]    [Pg.104]   
See also in sourсe #XX -- [ Pg.57 ]




SEARCH



© 2024 chempedia.info